NCT04301765 2026-03-31
TEMEC
Seattle Institute for Biomedical and Clinical Research
Phase 2 Recruiting
Clinical Trials
62 trialsNCT01410942 2026-02-20
Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06295588 2025-11-26
Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
University of Rochester
Phase 2 Recruiting
NCT00489307 2025-11-12
Dexamethasone for Symptom Burden in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06482515 2025-07-03
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
University of Maryland, Baltimore
Phase 2 Recruiting
NCT05440227 2025-06-05
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
PhytoHealth Corporation
Phase 2 Recruiting
NCT02077621 2025-06-04
Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer
PhytoHealth Corporation
Phase 2 Withdrawn
NCT05546476 2025-05-31
PROACC-1
Pfizer
Phase 2 Completed
NCT02581059 2024-06-26
Efficacy of Ginseng for Patients on Regorafenib
Wake Forest University Health Sciences
Phase 2 Terminated
NCT05212701 2024-04-30
To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer
Dompé Farmaceutici S.p.A
Phase 2 Withdrawn
NCT05664009 2024-04-05
The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults
Canada Royal Enoch Phytomedicine Co., Ltd.
Phase 2 Recruiting
NCT05229029 2024-01-19
TCM
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT06151249 2023-11-30
Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy
Chung Shan Medical University
Phase 2 Unknown
NCT01334983 2023-11-18
REST
Mayo Clinic
Phase 2 Completed
NCT01466270 2021-10-20
Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
Wake Forest University Health Sciences
Phase 2 Completed
NCT01032200 2021-09-28
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Wake Forest University Health Sciences
Phase 2 Completed
NCT01381718 2021-08-13
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
University of South Florida
Phase 2 Completed
NCT02940223 2021-06-10
Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02046837 2021-04-13
ADT Ex RCT
University Health Network, Toronto
Phase 2 Completed
NCT00112749 2020-07-31
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Terminated
NCT00866970 2020-07-09
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
CSL Behring
Phase 2 Completed
NCT04104113 2020-06-16
HERBAL
National University of Singapore
Phase 2 Unknown
NCT00993928 2019-12-03
Home-Based Programs for Improving Sleep in Cancer Survivors
Alliance for Clinical Trials in Oncology
Phase 2 Terminated
NCT01740323 2019-09-18
Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy
Emory University
Phase 2 Completed
NCT01002755 2019-05-07
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03911921 2019-04-16
RSYR for Fatigue Reduction in Cancer Survivors
Peking University Cancer Hospital & Institute
Phase 2 Completed
NCT01011218 2018-11-29
Management of Insomnia in Breast Cancer Patients
Stanford University
Phase 2 Completed
NCT03282214 2018-05-22
A Self-Management Energy Conservation Program for Cancer-Related Fatigue
University of Michigan
Phase 2 Completed
NCT02434367 2017-12-14
WWE
The West Clinic, Memphis
Phase 2 Completed
NCT00825227 2017-11-17
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Terminated
NCT02521077 2017-06-27
Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer
Midwestern Regional Medical Center
Phase 2 Withdrawn
NCT00397930 2017-02-20
YOCAS
University of Rochester
Phase 2 Completed
NCT01091974 2017-02-09
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
University of Rochester
Phase 2 Completed
NCT02645175 2016-10-21
Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
Meriyana Bio Inc.
Phase 2 Terminated
NCT00766467 2016-07-28
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01926678 2016-07-11
Efficacy of Swedish Massage Therapy on Cancer-related Fatigue in Cancer Survivors
Emory University
Phase 2 Completed
NCT00005850 2016-07-04
Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT01572168 2016-02-05
Acupuncture for the Treatment of Cancer Related Fatigue
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 2 Terminated
NCT00178373 2015-12-23
Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer
University of Rochester
Phase 2 Completed
NCT02288078 2014-11-13
Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)
Clinical Research Support Center Kyush
Phase 2 Unknown
NCT00593853 2014-06-04
Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy
University Health Network, Toronto
Phase 2 Terminated
NCT01348607 2014-02-21
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
University of South Florida
Phase 2 Terminated
NCT01669460 2013-12-19
Study of Red Bullâ„¢ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy
University Health Network, Toronto
Phase 2 Completed
NCT01400958 2013-12-16
Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT00379353 2013-02-04
The Effects of Thalidomide on Symptom Clusters
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01206335 2012-11-27
Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia
Ohr Pharmaceutical Inc.
Phase 2 Unknown
NCT00959998 2012-06-26
Acupressure for Post-Treatment Cancer Fatigue
University of Michigan
Phase 2 Completed
NCT00004914 2012-06-06
Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
Northwestern University
Phase 2 Completed
NCT00004912 2012-05-30
Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
Northwestern University
Phase 2 Completed
NCT00764231 2012-02-08
A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)
Toronto Rehabilitation Institute
Phase 2 Completed